Anna Falanga

Evaluation of nucleated red blood cell count by Sysmex XE-2100 in patients with thalassaemia or sickle cell anaemia and in neonates.

Giuseppe Lippi, Sabrina Buoro, Mauro Vavassori, 2015, Blood transfusion = Trasfusione del sangue.

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up

Yutao Guo, Harlan M. Krumholz, Yu Hu, 2020, Journal of the American College of Cardiology.

Summary and Conclusions

A. Falanga, H. ten Cate, Hugo ten Cate, 2009, Pathophysiology of Haemostasis and Thrombosis.

Cancer, thrombosis and heparin-induced thrombocytopenia.

Paolo Prandoni, P. Prandoni, A. Falanga, 2007, Thrombosis research.

Monitoring thrombin generation: Is addition of corn trypsin inhibitor needed?

A. Falanga, K. Hamulýak, Anna Falanga, 2009, Thrombosis and Haemostasis.

American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.

Gary H Lyman, Mohammad Jahanzeb, David Trent, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014.

Gary H Lyman, Christopher R Flowers, C. Flowers, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Hemostatic biomarkers in cancer progression.

A. Falanga, Anna Falanga, Marina Marchetti, 2018, Thrombosis research.

Clotting mechanisms and cancer: implications in thrombus formation and tumor progression.

A. Falanga, Anna Falanga, Marina Marchetti, 2003, Clinical advances in hematology & oncology : H&O.